The place of emollients in the prevention of atopic dermatitis
S. N. Nezabudkin, A. S. Nezabudkina, I. S. Sardaryan, V. V. Pogorelchuk

St. Petersburg State Pediatric Medical University

It is known that one of the factors causing the development of atopic dermatitis (AtD) is a violation of the barrier and protective functions of the skin. Emollients (softening and moisturizing creams, bathing products) are appointed to all the patients with AtD or with a risk of its developing, regardless of AtD severity, area, acuity of the skin process, presence or absence of complications.
The aim of the study was to prevent the AtD by the use of emollients in children of early age with known history of allergies.
Patients and Methods: 40 children participated in the study, aged 0 to 6 months. The observation period was 3 months.
Results: in group 1 the evaluation of the efficacy of the prophylactic administration of Atopic emollients was made during 3 months of observation. In all children of this group there were no manifestations of AtD during the time of observation. In the second group, where simple skin care products (soap, shampoo) were used, 17 children had manifestations of mild AtD (SCORAD 6.9 ± 1.4). To these children pimecrolimus was administered with a positive effect. 2 children had moderate to severe AtD manifestations (SCORAD 24,2 ± 2,7) which required methylprednisolone administration.
Conclusions: thus, the conducted study confirmed the necessity of using Atopik emollients for children with a history of allergies to prevent the development of AtD. A wide range of Atopic products allows to use them as a basic care, and as an additional means to topical anti-inflammatory therapy. No adverse reactions were observed during the use of these agents.

Key words: atopic dermatitis, epidermal barrier dysfunction, basic skin care algorithm, emollients, Atopic, methylprednisolone, pimecrolimus, simple skin care products.
For citation: Nezabudkin S.N., Nezabudkina A.S., Sardaryan I.S., Pogorelchuk V.V. The place of emollients in the prevention of atopic dermatitis // RMJ. 2018. № 2(II). P. 122–124.